Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.64 is 239% above its 4-year average of 0.78, near the low end of its 4-year range (0.00–12.48).
As of the fiscal period ended Tuesday, June 30, 2026. 38.42% above its 12-month average of 1.91.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.64.
QUICK RATIO (ACID-TEST)
2.64
QUICK RATIO (ACID-TEST) AVG TTM
1.91
QUICK RATIO (ACID-TEST) AVG 3Y
1.39
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+38.42%
CURRENT VS 3Y AVG
+89.87%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.11
median of 696 covered companies
CURRENT VS SECTOR MEDIAN
-15.00%
vs the sector median at left
FibroBiologics, Inc. Common Stock
Market Cap
$2.58M
Quick Ratio (Acid-Test)
2.64
TTM Avg
1.91
3Y Avg
1.39
5Y Avg
N/A
Market Cap
$2.58M
Quick Ratio (Acid-Test)
1.41
TTM Avg
1.72
3Y Avg
3.92
5Y Avg
2.64
Market Cap
$2.52M
Quick Ratio (Acid-Test)
0.40
TTM Avg
0.70
3Y Avg
0.81
5Y Avg
0.98
Market Cap
$2.48M
Quick Ratio (Acid-Test)
0.94
TTM Avg
1.19
3Y Avg
3.93
5Y Avg
6.93
Market Cap
$2.33M
Quick Ratio (Acid-Test)
12.73
TTM Avg
22.34
3Y Avg
19.49
5Y Avg
14.70
Market Cap
$2.33M
Quick Ratio (Acid-Test)
2.14
TTM Avg
0.35
3Y Avg
1.93
5Y Avg
12.75
Market Cap
$2.33M
Quick Ratio (Acid-Test)
1.54
TTM Avg
2.65
3Y Avg
3.41
5Y Avg
4.73
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| FibroBiologics, Inc. Common Stock (FBLG) | $2.58M | 2.64 | 1.91 | 1.39 | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.58M | 1.41 | 1.72 | 3.92 | 2.64 |
| Nuwellis, Inc. (NUWE)vs › | $2.62M | 1.54 | 1.94 | 2.53 | 3.69 |
| Jaguar Health, Inc. (JAGX)vs › | $2.52M | 0.40 | 0.70 | 0.81 | 0.98 |
| iSpecimen Inc. (ISPC)vs › | $2.64M | 0.82 | 0.87 | 1.93 | 3.50 |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.48M | 0.94 | 1.19 | 3.93 | 6.93 |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.33M | 12.73 | 22.34 | 19.49 | 14.70 |
| Onconetix, Inc. (ONCO)vs › | $2.33M | 2.14 | 0.35 | 1.93 | 12.75 |
| GeoVax Labs, Inc. (GOVX)vs › | $2.33M | 1.54 | 2.65 | 3.41 | 4.73 |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.04M | 1.15 | 2.58 | 1.43 | 2.20 |
Quick Ratio
2.64
Excludes inventory
Current Ratio
2.64
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.64 |
| 2026-03-31 | 1.59 |
| 2025-12-31 | 3.61 |
| 2025-09-30 | 0.78 |
| 2025-06-30 | 0.93 |
| 2025-03-31 | 1.14 |
| 2024-12-31 | 1.12 |
| 2024-09-30 | 1.23 |
| 2024-06-30 | 0.64 |
| 2024-03-31 | 0.64 |
| 2023-12-31 | 1.00 |
| 2023-09-30 | 8.31 |
| 2023-06-30 | 12.48 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 0.00 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.00 |
